|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/42 | (2006.01) |
| A61P 9/00 | (2006.01) | ||
| C07D 261/00 | (2006.01) | ||
| C07D 413/14 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/397 | (2006.01) | ||
| A61K 31/4245 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/444 | (2006.01) | ||
| C07D 413/10 | (2006.01) | ||
| C07D 261/04 | (2006.01) |
| (11) | Number of the document | 3174537 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15827553.7 |
| Date of filing the European patent application | 2015-07-24 | |
| (97) | Date of publication of the European application | 2017-06-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/041871 |
| Date | 2015-07-24 |
| (87) | Number | WO 2016/018729 |
| Date | 2016-02-04 |
| (30) | Number | Date | Country code |
| 201462030229 P | 2014-07-29 | US |
| (72) |
SHAO, Pengcheng Patrick , US
YE, Feng , US
VACHAL, Petr , US
THATAI, Jayanth Thiruvellore , IN
|
| (73) |
Merck Sharp & Dohme Corp. ,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | MONOCYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN |
| MONOCYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN |